Heme oxygenase 1 (HO-1): An auspicious target for state of the art anti-angiogenic therapeutic strategies and new insights in prostate carcinogenesis

被引：0
|
作者：
Gueron, Geraldine [1 ]
Ferrando, Mercedes [1 ]
Elguero, Belen [1 ]
Giudice, Jimena [1 ]
Salles, Angeles [1 ]
Labanca, Estefania [1 ]
Jaworsky, Felipe [1 ]
Colombo, Lucas [2 ]
Meiss, Roberto [3 ]
Navone, Nora [4 ]
De Siervi, Adriana [1 ]
Vazquez, Elba [1 ]
机构：
[1] Univ Buenos Aires, Sch Sci, Buenos Aires, DF, Argentina
[2] Inst Oncol AH Roffo, Buenos Aires, DF, Argentina
[3] Natl Acad Med Buenos Aires, Inst Oncol Studies, Buenos Aires, DF, Argentina
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-5290
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5290
引用
收藏
页数：1
相关论文
共 37 条
  • [1] Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer
    M. Ferrando
    G. Gueron
    B. Elguero
    J. Giudice
    A. Salles
    F. Coluccio Leskow
    E. A. Jares-Erijman
    L. Colombo
    R. Meiss
    N. Navone
    A. De Siervi
    E. Vazquez
    Angiogenesis, 2011, 14 : 467 - 479
  • [2] Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer
    Ferrando, M.
    Gueron, G.
    Elguero, B.
    Giudice, J.
    Salles, A.
    Leskow, F. Coluccio
    Jares-Erijman, E. A.
    Colombo, L.
    Meiss, R.
    Navone, N.
    De Siervi, A.
    Vazquez, E.
    ANGIOGENESIS, 2011, 14 (04) : 467 - 479
  • [3] Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer
    Vazquez, Elba S.
    Gueron, Geraldine
    Ferrando, Mercedes
    Elguero, Belen
    Salles, Angeles
    De Siervi, Adriana
    VASCULAR PHARMACOLOGY, 2012, 56 (5-6) : 370 - 371
  • [4] Identification of heme oxygenase 1 (HO-1=Hsp32) as a critical survival factor and new therapeutic target in aml
    Kneidinger, M.
    Gleixner, K. V.
    Kondo, R.
    Samorapoompichit, P.
    Vales, A.
    Krauth, M.-T.
    Mayerhofer, M.
    Gruze, A.
    Pickl, W. F.
    Greish, K.
    Boehm, A.
    Sperr, W. R.
    Maeda, H.
    Valent, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 12 - 12
  • [5] Deficiency of Heme oxygenase-1 (HO-1) leads to a Proinflammatory state.
    Pittock, ST
    Croatt, AJ
    Griffin, MD
    Nath, KA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 624A - 624A
  • [6] Identification of heme oxygenase-1 (HO-1=Hsp32) as a novel therapeutic target in canine mastocytoma cells
    Hadzijusufovic, E. H.
    Rebuzzi, L.
    Gleixner, K. V.
    Vales, A.
    Kondo, R.
    Gruze, A.
    Kneidinger, M.
    Krauth, M. T.
    Samoorapoompichit, P.
    Greish, K.
    Mayerhofer, M.
    Pickl, W. F.
    Hiroshi, M.
    Willman, M.
    Valent, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 489 - 490
  • [7] Myeloid heme oxygenase-1: a new therapeutic target in anti-inflammation
    Zhao, Mingyi
    Yang, Minghua
    Que, Weitao
    Zhong, Lin
    Fujino, Masayuki
    Li, Xiao-Kang
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2018, 23 : 2001 - 2015
  • [8] HO-1: A new potential therapeutic target to combat osteoporosis
    Che, Jingmin
    Yang, Jiancheng
    Zhao, Bin
    Shang, Peng
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 906
  • [9] EXPLORING THE POTENTIAL OF HAEME-OXYGENASE 1 (HO-1) AS A THERAPEUTIC TARGET FOR PAH ASSOCIATED WITH CTD
    Elies, J.
    Peers, C. C.
    Del Galdo, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : A71 - A71
  • [10] The therapeutic benefits of heme oxygenase (HO-1) inhibition in the management of systemic malignancies besides hepatocellular carcinomas
    Kapoor, Shailendra
    INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (03) : 736 - 736
1234